Welcome! Login | Register
 

Elorza’s Spending Binge on Attorneys Draws Fire — See Which Firms Raked in the Most—Elorza’s Spending Binge on Attorneys Draws Fire —…

Riley: Pros Predictions for Beating the Treasurer in 2017—Riley: Pros Predictions for Beating the Treasurer in…

Providence Students Planning Walkout to Protest Trump Inauguration Friday—Providence Students Planning Walkout to Protest Trump Inauguration…

Guest MINDSETTER™ Seyler: Critical Spending Requires Critical Thinking at CCRI—Guest MINDSETTER™ Seyler: Critical Spending Requires Critical Thinking…

Horowitz: President Obama - A Consequential and Successful Presidency—Horowitz: President Obama - A Consequential and Successful…

Organize + Energize: How Much do You Need to be Happy?—Organize + Energize: How Much do You Need…

Cartwright’s Near Triple-Double Leads PC Past Georgetown 74-56—Cartwright's Near Triple-Double Leads PC Past Georgetown 74-56

New England Fleece Blankets to be Used at Presidential Inauguration—New England Fleece Blankets to be Used at…

Steelers’ Tomlin Calls Patriots “A-Holes” in Facebook Live Video—NEW: Steelers' Tomlin Calls Patriots "A-Holes" in Facebook…

RI Gas Prices Drop 4 Cents From Last Week—RI Gas Prices Drop 4 Cents From Last…

 
 

NEW: Women & Infants Physician Sandra Carson Earns FDA Award

Friday, May 18, 2012

 

Women & Infants physician Sandra A. Carson receives an honor from the FDA.

The United States Food and Drug Administration (FDA) recently honored Sandra A. Carson, MD, with an FDA Advisory Committee Distinguished Service Award for 2011.

Dr. Carson, who is medical director of the Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and director of the hospital’s Division of Reproductive Endocrinology and Infertility, served as a member and chair of the Advisory Committee for Reproductive Health Drugs for several years.

Sandra Carson: "A powerful force"

“When Dr. Carson arrived at Women & Infants, we knew she was a powerful force in the field of reproduction and infertility in the world,” says Constance Howes, president and CEO of Women & Infants. “Since then, she has continued to amaze with her dedication to the couples struggling with infertility, at both a local, national and international level. This award reflects the depth of her commitment to her field.”

The FDA maintains a host of advisory committees, including those focused on various categories of drugs. The committee members, who are chosen by the FDA commissioner, provide independent opinions and recommendations on applications to market new drugs and on FDA policies. The FDA generally follows the advisory committee’s recommendations but it is not bound to do so.

The Advisory Committee for Reproductive Health Drugs is charged with reviewing and evaluating data on the safety and effectiveness of marketed and investigational human drugs for use in the practice of obstetrics, gynecology, and related subspecialties, and make appropriate recommendations to the Commissioner of Food and Drugs.

Top doc in the US

Dr. Carson, a reproductive endocrinologist, is on the U.S. News & World Report’s Top Doctors list as being among the top 1% in the nation in her specialty. A professor at The Warren Alpert Medical School of Brown University, Dr. Carson was part of the Brown-Women & Infants research team that in 2010 invented the world’s first artificial human ovary, a new tool in fertility research. It can mature human eggs in the laboratory and could help preserve the fertility of women facing chemotherapy or other treatments.

For more Health coverage, don't miss GoLocalTV, fresh every day at 4pm and on demand 24/7, here.

 

Related Articles

 

Enjoy this post? Share it with others.

 
Delivered Free Every
Day to Your Inbox
 
:!